MedPath

Incidence and Relationship of Positive Preoperative Methicillin Resistant Staphylococcus Aureus (MRSA) Screens and Post-operative Infections

Not Applicable
Terminated
Conditions
Methicillin-resistant Staphylococcus Aureus Infection
Interventions
Other: Preoperative MRSA screening
Registration Number
NCT01028105
Lead Sponsor
Inova Health Care Services
Brief Summary

The purpose of this study is to evaluate the prevalence of pre-surgical patients who are MRSA carriers. From an evidence-based practice perspective, findings from this study can be considered in the evaluation of the hospital SOP mandating pre-surgical MRSA screening requirements for patients with scheduled surgeries.

The central hypothesis to be addressed in this study is whether the MRSA colonization and subsequent post-operative infection are the equivalent in these populations.

Detailed Description

Design and Methods: Subjects in this study of 975 pre-operative, scheduled surgical patients are in one of the three following groups:

* Group 1 (N=325): Allocation sample of surgical patients required to be MRSA screened per hospital SOP (including patients having a positive MRSA history, orthopedic surgery, undergoing dialysis, or transfer from another hospital, nursing home, skilled nursing facility, or jail).

* Group 2 (N=650): Randomized sample (1:1 ratio) of surgical patients not required to be MRSA screened per hospital SOP, to one of the following two groups:

* 2a (N=325): MRSA screening; or

* 2b (N=325): No MRSA screening. All subjects were followed for 30 days post-operatively to determine the incidence of post-operative infection. Treatment, diagnostic, and hospitalization data were collected for patients diagnosed with post-operative infection.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
975
Inclusion Criteria
  1. Pre-surgical out patient at ILH
  2. Surgical procedure scheduled at least 2 days before surgery
  3. Surgery being done at ILH operating room
  4. Provision of signed ICF
Exclusion Criteria
  1. Patient 18 years of age or older who is deemed by the hospital incapable of providing Informed Consent
  2. Inability to communicate in the English language

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MRSA screening, Group aPreoperative MRSA screeningMRSA preoperative screening
Primary Outcome Measures
NameTimeMethod
The primary objective of this study is to compare the prevalence of MRSA colonization and its relationship to post-operative infection in patients who are currently pre-operatively MRSA screened per SOP to those who are not.30 days
Secondary Outcome Measures
NameTimeMethod
The secondary objective is to compare medical charges associated with diagnosis and treatment of post-operative infections for these groups using cost-effectiveness analysis.30 days

Trial Locations

Locations (2)

Inova Health Care Services

🇺🇸

Falls Church, Virginia, United States

Inova Loudoun Hospital

🇺🇸

Leesburg, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath